Log In
Print
BCIQ
Print
Print this Print this
 

ISIS-EIF4ERx (formerly LY2275796)

Also known as: eIF4E binding protein 2 antisense (eIF-4E ASO)

  Manage Alerts
Collapse Summary General Information
Company Isis Pharmaceuticals Inc.
DescriptionSecond-generation antisense compound targeting eukaryotic translation initiation factor 4E (eIF4E)
Molecular Target Eukaryotic translation initiation factor 4E (eIF4E)
Mechanism of ActionAntisense therapy
Therapeutic ModalityNucleic acid: Linear RNA: Antisense

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today